Marker Therapeutics, Inc.

US$0.89As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:MRKRHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (33.08%)
Div yield —
ROE (76.87%)
Biotechnology
Beta (5Y) 1.62
PE TTM —
TSR TTM (9.61%)
Mkt cap US$14.89M
ROIC (52.43%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.927
3.86%
(28.77%)
Hold 9|7|10|9|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.03
0.03
0.03
28.97%
29.04%
38.15%
19.40%
Revenue$M
0.688
0.707
0.737
0.781
6.24%
4.80%
9.28%
11.01%
Peers (US$14.89M)
Cap (US$)
PE
15.10M
0.082x
Capital
TTM
5Y
10Y
Leveragex
0.602
—
—
EBIT/Intx
2.413
0.043
0.051
Own earn%
(150.37)
(32.18)
(36.43)
Sh yield%
34.12
44.64
47.43
Owners
Insiders/Inst%
1.29
59.62
Short interest%
3.55
SBC / revenue%
0.42
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
14–25
$1 testx
—
Incr. ROIC%
4